Cleared Traditional

K152676 - FD TENS 2090, FD TENS 2095

K152676 is an FDA 510(k) clearance for FD TENS 2090, manufactured by Fuji Dynamics , Ltd.. The device is a Class 2 Neurology device with product code GZJ cleared through the Traditional 510(k) pathway after a 126-day FDA review.

K152676 · Fuji Dynamics , Ltd. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2016
Decision
126d
Days
Class 2
Risk

K152676 is an FDA 510(k) clearance for the FD TENS 2090, FD TENS 2095. Classified as Stimulator, Nerve, Transcutaneous, For Pain Relief (product code GZJ), Class II - Special Controls.

Submitted by Fuji Dynamics , Ltd. (Hong Kong, CN). The FDA issued a Cleared decision on January 22, 2016 after a review of 126 days - within the typical 510(k) review window.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Fuji Dynamics , Ltd. devices

FDA 510(k) Submission Details - K152676

510(k) Number K152676 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 18, 2015
Decision Date January 22, 2016
Days to Decision 126 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
23d faster than avg
Panel avg: 149d · This submission: 126d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZJ Device Classification - Class 2, Special Controls

Product Code GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

All 330
Devices cleared under the same product code (GZJ) and FDA review panel - the closest regulatory comparables to K152676.
WELL LIFE Rx Wireless TENS/EMS Stimulator, model WR-2603/2603A, WR-2604/2604A and WR-2605/2605A
K162663 · Well-Life Healthcare Limited · Jan 2017
SimulCare II(TM)
K160246 · Xanacare Technologies, LLC · Oct 2016
Strive
K153704 · Djo, LLC · Jun 2016
BiowaveHOME Neuromodulation Pain Therapy Device
K152437 · Biowave Corporation · Sep 2015
Synapse Transcutaneous Electrical Stimulation Device
K143198 · Synapse Electroceutical Limited · May 2015
Scrambler Therapy MC-5 A Device
K142666 · Delta International Services & Logistics S.R.L · May 2015